FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

13941411000001107: Norprolac 75microgram tablets (Doncaster Pharmaceuticals Ltd) 30 tablet (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
49965201000001118 Norprolac 75microgram tablets (Doncaster Pharmaceuticals Ltd) 30 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
78266101000001112 Norprolac 75microgram tablets (DE Pharmaceuticals) 30 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Norprolac 75microgram tablets (Doncaster Pharmaceuticals Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Norprolac 75microgram tablets (Doncaster Pharmaceuticals Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Norprolac 75microgram tablets (Doncaster Pharmaceuticals Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Norprolac 75microgram tablets (Doncaster Pharmaceuticals Ltd) 30 tablet Is a Quinagolide 75microgram tablets 30 tablet true Inferred relationship Existential restriction modifier
Norprolac 75microgram tablets (Doncaster Pharmaceuticals Ltd) 30 tablet Is pack of Norprolac 75microgram tablets (Doncaster Pharmaceuticals Ltd) false Inferred relationship Existential restriction modifier
Norprolac 75microgram tablets (Doncaster Pharmaceuticals Ltd) 30 tablet Has active ingredient Quinagolide false Inferred relationship Existential restriction modifier
Norprolac 75microgram tablets (Doncaster Pharmaceuticals Ltd) 30 tablet Has active ingredient Quinagolide hydrochloride false Inferred relationship Existential restriction modifier
Norprolac 75microgram tablets (Doncaster Pharmaceuticals Ltd) 30 tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Norprolac 75microgram tablets (Doncaster Pharmaceuticals Ltd) 30 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Norprolac 75microgram tablets (Doncaster Pharmaceuticals Ltd) 30 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Norprolac 75microgram tablets (Doncaster Pharmaceuticals Ltd) 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Norprolac 75microgram tablets (Doncaster Pharmaceuticals Ltd) 30 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Norprolac 75microgram tablets (Doncaster Pharmaceuticals Ltd) 30 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Norprolac 75microgram tablets (Doncaster Pharmaceuticals Ltd) 30 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Norprolac 75microgram tablets (Doncaster Pharmaceuticals Ltd) 30 tablet Has AMP Norprolac 75microgram tablets (Doncaster Pharmaceuticals Ltd) true Inferred relationship Existential restriction modifier
Norprolac 75microgram tablets (Doncaster Pharmaceuticals Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Quinagolide true Inferred relationship Existential restriction modifier
Norprolac 75microgram tablets (Doncaster Pharmaceuticals Ltd) 30 tablet Has specific active ingredient Quinagolide hydrochloride false Inferred relationship Existential restriction modifier
Norprolac 75microgram tablets (Doncaster Pharmaceuticals Ltd) 30 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Norprolac 75microgram tablets (Doncaster Pharmaceuticals Ltd) 30 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Norprolac 75microgram tablets (Doncaster Pharmaceuticals Ltd) 30 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Norprolac 75microgram tablets (Doncaster Pharmaceuticals Ltd) 30 tablet Has basis of strength substance Quinagolide true Inferred relationship Existential restriction modifier
Norprolac 75microgram tablets (Doncaster Pharmaceuticals Ltd) 30 tablet Has specific active ingredient Quinagolide hydrochloride true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start